103,859 Shares in JAN $JAN Acquired by WINTON GROUP Ltd

Key Points

• WINTON GROUP Ltd acquired 103,859 JAN shares worth approximately $3.0 million during the second quarter. Several other institutional investors also initiated positions, though institutional and hedge-fund ownership remains 6.27%.
• Analyst sentiment is favorable, with a consensus “Moderate Buy” rating and a $31.71 price target. Recent upgrades include Wells Fargo, Scotiabank, Barclays, and Huntington, which set a $36 target.
• JAN reported 45.4% year-over-year revenue growth to $216.5 million, exceeding estimates, but quarterly EPS of $0.05 missed expectations of $0.23. The company reaffirmed fiscal 2026 EPS guidance of $0.95–$0.98 and announced a $0.0475 monthly dividend.

WINTON GROUP Ltd purchased a new stake in JAN (NYSE:JAN - Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 103,859 shares of the company's stock, valued at approximately $2,985,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. Wellington Management Group LLP acquired a new position in shares of JAN in the 2nd quarter valued at about $8,739,000. Readystate Asset Management LP acquired a new position in JAN during the 2nd quarter worth approximately $1,724,000. Greenland Capital Management LP acquired a new stake in JAN in the second quarter valued at approximately $575,000. Finally, Engineers Gate Manager LP purchased a new stake in shares of JAN during the second quarter valued at approximately $15,274,000. 6.27% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

JAN has been the topic of several analyst reports. Wells Fargo & Company lifted their price target on shares of JAN from $33.00 to $35.00 and gave the stock an "overweight" rating in a research note on Tuesday, September 1st. Scotiabank increased their target price on JAN from $30.00 to $31.00 and gave the company an "outperform" rating in a research note on Wednesday, September 2nd. UBS Group set a $29.00 price target on shares of JAN in a research report on Thursday, June 18th. Raymond James Financial started coverage on shares of JAN in a report on Tuesday, June 16th. They issued a "strong-buy" rating and a $34.00 price target on the stock. Finally, Barclays raised their price objective on shares of JAN from $33.00 to $34.00 and gave the stock an "overweight" rating in a report on Monday, August 31st. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $31.71.

JAN News Roundup

Here are the key news stories impacting JAN this week:

• Positive Sentiment: Huntington initiated coverage of JAN with an “Outperform” rating and a $36 price target, implying approximately 17% upside from the reported reference price of $30.76. The new bullish coverage may improve investor sentiment and broaden institutional awareness of the stock. Huntington initiates JAN coverage
• Positive Sentiment: The company’s latest reported quarter showed revenue of $216.5 million, up 45.4% year over year and above analyst expectations of $203.3 million. Management also provided fiscal 2026 EPS guidance of $0.95 to $0.98, broadly consistent with the analyst consensus of $0.97.
• Neutral Sentiment: JAN previously reported quarterly EPS of $0.05, below the $0.23 consensus estimate. The earnings miss remains a risk, although strong revenue growth and the reaffirmed full-year outlook may be cushioning its impact.
• Neutral Sentiment: Recent JAN-related articles about JAN-PRO cleaning standards and the consumer software application “Jan” do not appear to provide material new information about the publicly traded company and are unlikely to be significant stock catalysts.

JAN Stock Up 0.3%

NYSE JAN opened at $30.91 on Friday. JAN has a one year low of $22.76 and a one year high of $32.83. The firm has a 50-day simple moving average of $30.38.

JAN (NYSE:JAN - Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.23 by ($0.18). The business had revenue of $216.46 million during the quarter, compared to the consensus estimate of $203.32 million. JAN's quarterly revenue was up 45.4% compared to the same quarter last year. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. Equities analysts forecast that JAN will post 0.97 EPS for the current year.

JAN Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Friday, September 11th will be given a $0.0475 dividend. The ex-dividend date of this dividend is Friday, September 11th. This represents a c) annualized dividend and a yield of 1.8%.

JAN Profile

JanOne Inc is a technology and life sciences company focused on addressing the global opioid crisis. The company's activities include developing and supporting pharmaceutical and other solutions intended to help reduce opioid-related deaths and dependency.

JanOne has also pursued blockchain and financial technology initiatives through its Alt 5 Sigma operations. These activities have included blockchain-based payment, digital asset and financial services solutions designed to help businesses manage transactions and related digital assets.

The company serves markets through its healthcare, technology and financial services initiatives, with an emphasis on solutions that can be applied internationally.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.